English

CureVac N.V.

EDGAR

CVAC Report (type unavailable) · filed 2025-11-26

Annual consolidated revenue for 2024: about Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 535.2M, using the latest reported figures. The previous period, 2023, was about Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 53.76M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.25 million Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g

2025 Q2 · Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g

Exact inputs and evidence

Revenue: 1245000 Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g Source

Operating margin

-4,959.52%

2025 Q2 · %

Exact inputs and evidence

Operating Income: -61746000 Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g Source
Revenue: 1245000 Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g Source

Cash and cash equivalents: 393 million Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g 2025-06-30 Source
Exact value

392703000 Unit_Standard_EUR_AqOUkcCorkKAHkd2ya_S9g
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-11-26.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2024-12-31
Operating income: 3 of 11 periods available· newest 2024-12-31
net income: No compatible figures in this window
Operating cash flow: 3 of 11 periods available· newest 2024-12-31
Capital expenditure: 3 of 11 periods available· newest 2024-12-31
Total assets: Multiple units; comparison withheld· newest 2024-12-31
Total liabilities: Multiple units; comparison withheld· newest 2024-12-31
Current assets: Multiple units; comparison withheld· newest 2024-12-31
Current liabilities: Multiple units; comparison withheld· newest 2024-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2024-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+895.5%

Prior period

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 53.76 million

2023-01-01 – 2023-12-31
Current period

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 535.18 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

535180000 − 53758000 = 481422000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw

53758000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
535180000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CureVac N.V. · 2024-12-31 CureVac N.V. (edgar:1809122) Year-over-year change in Revenue: 481422000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 535180000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#3166093 Filing: 000141057825000692 Input fundies:Revenue: 53758000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#3165216 Filing: 000141057825000692
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 369.74 million

Prior period

−Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 267.89 million

2023-01-01 – 2023-12-31
Current period

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 101.85 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

101851000 − -267887000 = 369738000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw

-267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CureVac N.V. · 2024-12-31 CureVac N.V. (edgar:1809122) Year-over-year change in Operating cash flow: 369738000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2988672 Filing: 000141057825000692 Input fundies:OperatingCashFlow: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2987799 Filing: 000141057825000692
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-72.6%

Prior period

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 52.32 million

2023-01-01 – 2023-12-31
Current period

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 14.32 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

14315000 − 52320000 = -38005000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw

52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CureVac N.V. · 2024-12-31 CureVac N.V. (edgar:1809122) Year-over-year change in Capital expenditure: -38005000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2994208 Filing: 000141057825000692 Input fundies:CapitalExpenditure: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2993399 Filing: 000141057825000692
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 535.18 million 100% of revenue
Operating costs Derived Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 357.5 million 67% of revenue
Operating income Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 177.68 million 33% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 101.85 million 19% of revenue
Capital expenditure Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 14.32 million 2.7% of revenue
Free cash flow Derived Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 87.54 million 16% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2022 2022-01-01 – 2022-12-31	67420000	316877000 Derived	-249457000	Unavailable	Unavailable	-374200000 Derived	Source 2022-01-01 – 2022-12-31: 67420000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Revenue Open source 2022-01-01 – 2022-12-31: -249457000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	53758000	327965000 Derived	-274207000	Unavailable	Unavailable	-320207000 Derived	Source 2023-01-01 – 2023-12-31: 53758000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Revenue Open source 2023-01-01 – 2023-12-31: -274207000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	535180000	357498000 Derived	177682000	Unavailable	Unavailable	87536000 Derived	Source 2024-01-01 – 2024-12-31: 535180000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Revenue Open source 2024-01-01 – 2024-12-31: 177682000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Capital Expenditure Open source

Amounts are exact, in Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 535.2M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw)	Source evidence
20222022-12-31	Revenue	67420000	Revenue: 67420000 Open source
20232023-12-31	Revenue	53758000	Revenue: 53758000 Open source
20242024-12-31	Revenue	535180000	Revenue: 535180000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

895.5% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Year over year	No prior comparable period	Revenue: 67420000 Open source
20232023-12-31	Year over year	-20.3%	Revenue: 53758000 Open source Revenue: 67420000 Open source
20242024-12-31	Year over year	895.5%	Revenue: 535180000 Open source Revenue: 53758000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 33.2% 2024

Free cash flow margin 16.4% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Operating margin	-370%	Operating Income: -249457000 Open source Revenue: 67420000 Open source
20232023-12-31	Operating margin	-510.1%	Operating Income: -274207000 Open source Revenue: 53758000 Open source
20242024-12-31	Operating margin	33.2%	Operating Income: 177682000 Open source Revenue: 535180000 Open source
2022-12-31	Net margin	Not reported	Revenue: 67420000 Open source
2023-12-31	Net margin	Not reported	Revenue: 53758000 Open source
2024-12-31	Net margin	Not reported	Revenue: 535180000 Open source
20222022-12-31	Free cash flow margin	-555%	Revenue: 67420000 Open source Operating Cash Flow: -286177000 Open source Capital Expenditure: 88023000 Open source
20232023-12-31	Free cash flow margin	-595.6%	Revenue: 53758000 Open source Operating Cash Flow: -267887000 Open source Capital Expenditure: 52320000 Open source
20242024-12-31	Free cash flow margin	16.4%	Revenue: 535180000 Open source Operating Cash Flow: 101851000 Open source Capital Expenditure: 14315000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 101.9M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw)	Source evidence
20222022-12-31	Operating cash flow	-286177000	Operating Cash Flow: -286177000 Open source
20232023-12-31	Operating cash flow	-267887000	Operating Cash Flow: -267887000 Open source
20242024-12-31	Operating cash flow	101851000	Operating Cash Flow: 101851000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 87.5M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw)	Source evidence
20222022-12-31	Free cash flow	-374200000	Operating Cash Flow: -286177000 Open source Capital Expenditure: 88023000 Open source
20232023-12-31	Free cash flow	-320207000	Operating Cash Flow: -267887000 Open source Capital Expenditure: 52320000 Open source
20242024-12-31	Free cash flow	87536000	Operating Cash Flow: 101851000 Open source Capital Expenditure: 14315000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2022-12-31	Liabilities / assets	Not reported	No source recorded
2023-12-31	Liabilities / assets	Not reported	No source recorded
2024-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2022-12-31	Current assets / current liabilities	Not reported	No source recorded
2023-12-31	Current assets / current liabilities	Not reported	No source recorded
2024-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2022 2022-01-01 – 2022-12-31	Unavailable Not reported for this period.	−Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 286.18 million Exact value Exact value: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2022-01-01 – 2022-12-31: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CureVac N.V. · 2022-12-31 CureVac N.V. (edgar:1809122) Operating Cash Flow: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw&dimensions= Input fundies:OperatingCashFlow: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2986942 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 88.02 million Exact value Exact value: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2022-01-01 – 2022-12-31: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CureVac N.V. · 2022-12-31 CureVac N.V. (edgar:1809122) Capital Expenditure: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw&dimensions= Input fundies:CapitalExpenditure: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2992607 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 374.2 million Calculation and evidence -286177000 − 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Exact free cash flow: -374200000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2022-01-01 – 2022-12-31: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CureVac N.V. · 2022-12-31 CureVac N.V. (edgar:1809122) Free cash flow: -374200000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -286177000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2986942 Filing: 000141057825000692 Input fundies:CapitalExpenditure: 88023000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2992607 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	Unavailable Not reported for this period.	−Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 267.89 million Exact value Exact value: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2023-01-01 – 2023-12-31: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CureVac N.V. · 2023-12-31 CureVac N.V. (edgar:1809122) Operating Cash Flow: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw&dimensions= Input fundies:OperatingCashFlow: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2987799 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 52.32 million Exact value Exact value: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2023-01-01 – 2023-12-31: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CureVac N.V. · 2023-12-31 CureVac N.V. (edgar:1809122) Capital Expenditure: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw&dimensions= Input fundies:CapitalExpenditure: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2993399 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 320.21 million Calculation and evidence -267887000 − 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Exact free cash flow: -320207000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2023-01-01 – 2023-12-31: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CureVac N.V. · 2023-12-31 CureVac N.V. (edgar:1809122) Free cash flow: -320207000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -267887000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2987799 Filing: 000141057825000692 Input fundies:CapitalExpenditure: 52320000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2993399 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	Unavailable Not reported for this period.	Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 101.85 million Exact value Exact value: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2024-01-01 – 2024-12-31: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CureVac N.V. · 2024-12-31 CureVac N.V. (edgar:1809122) Operating Cash Flow: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw&dimensions= Input fundies:OperatingCashFlow: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2988672 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 14.32 million Exact value Exact value: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2024-01-01 – 2024-12-31: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CureVac N.V. · 2024-12-31 CureVac N.V. (edgar:1809122) Capital Expenditure: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw&dimensions= Input fundies:CapitalExpenditure: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2994208 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 87.54 million Calculation and evidence 101851000 − 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Exact free cash flow: 87536000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw 2024-01-01 – 2024-12-31: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CureVac N.V. · 2024-12-31 CureVac N.V. (edgar:1809122) Free cash flow: 87536000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1809122?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 101851000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2988672 Filing: 000141057825000692 Input fundies:CapitalExpenditure: 14315000 Unit_Standard_EUR_UoO7Tm_WEEy57b4PDtvZDw (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1809122/000141057825000692/cvac-20241231x20f.htm#2994208 Filing: 000141057825000692 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

158 filings · 2,476 latest values · 2,476 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001809122, 1809122, CVAC, edgar:1809122

Also known as CureVac B.V., CureVac N.V.

CureVac N.V.

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation